Indication
Squamous Cell Carcinoma of Pancreas
1 clinical trial
4 products
Clinical trial
Phase Ib/II Open-Label, Multicenter, Randomized Study Evaluating the Safety and Efficacy of 'Switch Maintenance' Combination Immunotherapy Using AB154, AB122, and APX005M in Patients With Metastatic Pancreatic CancerStatus: Recruiting, Estimated PCD: 2026-01-31
Product
ZIMBERELIMABProduct
DOMVANALIMABProduct
APX005MProduct
FOLFIRI